CareDx Inc (CDNA) Stock Analysis

CareDx Inc (CDNA) is a publicly traded company in the HEALTHCARE sector. It trades at $22.07, carries a market capitalization of $1.18B. This page summarizes the public market data, fundamentals, and frequently asked questions for CDNA, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DIAGNOSTICS & RESEARCH

Exchange: NASDAQ

Key Metrics

• Price: $22.07
• Market Cap: $1.18B
• EPS: $-0.16
• 52-Week High: $23.24
• 52-Week Low: $10.96

Market Sentiment

CareDx Inc currently has a Neutral sentiment score of -0.11.

About CareDx Inc

CareDx, Inc. is a pioneering biotechnology company headquartered in South San Francisco, California, dedicated to transforming transplant medicine through advanced diagnostic solutions. The company specializes in innovative surveillance tools that significantly enhance transplant outcomes and facilitate personalized care for organ transplant recipients. With a comprehensive portfolio of cutting-edge tests and software platforms, CareDx is committed to improving the quality of life for patient...

GNG Research Analysis

GNG Research scores CareDx Inc (CDNA) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for CDNA.

Frequently Asked Questions

Does CDNA pay dividends?

CareDx Inc (CDNA) does not currently pay a regular dividend.

What is CDNA's market cap?

CareDx Inc (CDNA) has a market capitalization of $1.18B with a current stock price of $22.07.